Angelo Gordon & Co’s St Jude Medical STJ Stock Holding History

Angelo Gordon & Co’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-350,000	Closed	-$28.1M	–	86
2016 Q4	$28.1M	Sell	350,000 -150,000	-30%	-$11.9M	2.06%	14
2016 Q3	$39.9M	Buy	500,000 +225,000	+82%	+$18.2M	3.01%	9
2016 Q2	$21.4M	Buy	+275,000	New	+$19.6M	1.51%	20

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Angelo Gordon & Co's STJ Position: Q1 2017 in Review

Angelo Gordon & Co sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 350,000 shares — an estimated $28.1M sold.

Angelo Gordon & Co first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $39.9M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Angelo Gordon & Co reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Angelo Gordon & Co sold 350,000 St Jude Medical shares in Q1 2017, an estimated $28.1M.
Angelo Gordon & Co first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
Angelo Gordon & Co's St Jude Medical position peaked at $39.9M in Q3 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Angelo Gordon & Co's 13F filing for Q1 2017, filed 12 May 2017.